Double Blind Randomized Trial to Compare Gurmar (Gymnema Sylvestre) With Metformin in Type 2 Diabetes
Not Applicable
- Conditions
- Type 2 Diabetes Mellitus
- Registration Number
- NCT00396851
- Lead Sponsor
- Post Graduate Institute of Medical Education and Research, Chandigarh
- Brief Summary
The study plans to compare the glucose-lowering effect of gurmar, a herbal preparation, with metformin in patients with type 2 diabetes
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
- Newly detected type 2 diabetes
- Fasting plasma glucose >126mg/dl
- HbA1c > 7%
Exclusion Criteria
- Serious comorbid illnesss
- History of drug abuse
- History of recent weight loss
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie Gymnema Sylvestre's glucose-lowering effects in type 2 diabetes?
How does Gymnema Sylvestre compare to metformin in terms of efficacy for glycemic control in type 2 diabetes mellitus?
Are there specific biomarkers that can predict patient response to Gymnema Sylvestre in diabetes management?
What are the potential adverse events associated with Gymnema Sylvestre and how do they compare to metformin's safety profile?
What is the current status of herbal glucose-lowering agents in the therapeutic landscape of type 2 diabetes compared to conventional drug classes like biguanides and GLP-1 receptor agonists?
Trial Locations
- Locations (1)
PGIMER
🇮🇳Chandigarh, India
PGIMER🇮🇳Chandigarh, IndiaSamir MalhotraContactsamirmalhotra345@yahoo.comPromila Pandhi, MD,DMSub Investigator